About: Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
Creator	Wang, Yan Lin, Li Li, Sheng Zhao, Chunxia Wang, Hong Wang, X Wang, D Li, S Ma, Y Wang, C Zhao, J Guo, H Wang, Daowen Zeng, Hesong Zeng, Y Jiang, Jiangang Cui, Guanglin Guo, Xiaomei Ma, Yexin Tang, Jiarong Yan, Jiangtao Zuo, Houjuan
Source	PMC
abstract	Fulminant myocarditis is primarily caused by infection with any number of a variety of viruses. It arises quickly, progresses rapidly, and may lead to severe heart failure or circulatory failure presenting as rapid-onset hypotension and cardiogenic shock, with mortality rates as high as 50%–70%. Most importantly, there are no treatment options, guidelines or an expert consensus statement. Here, we provide the first expert consensus, the Chinese Society of Cardiology Expert Consensus Statement on the Diagnosis and Treatment of Fulminant Myocarditis, based on data from our recent clinical trial (NCT03268642). In this statement, we describe the clinical features and diagnostic criteria of fulminant myocarditis, and importantly, for the first time, we describe a new treatment regimen termed life support-based comprehensive treatment regimen. The core content of this treatment regimen includes (i) mechanical life support (applications of mechanical respirators and circulatory support systems, including intraaortic balloon pump and extracorporeal membrane oxygenation, (ii) immunological modulation by using sufficient doses of glucocorticoid, immunoglobulin and (iii) antiviral reagents using neuraminidase inhibitor. The proper application of this treatment regimen may and has helped to save the lives of many patients with fulminant myocarditis.
has issue date	2018-12-03(xsd:dateTime)
bibo:doi	10.1007/s11427-018-9385-3
bibo:pmid	30519877
has license	cc-by
sha1sum (hex)	c84af203275e3d64b400d55a36650584daba6274
schema:url	https://doi.org/10.1007/s11427-018-9385-3
resource representing a document's title	Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
has PubMed Central identifier	PMC7102358
has PubMed identifier	30519877
schema:publication	Sci China Life Sci
resource representing a document's body	covid:c84af203275e3d64b400d55a36650584daba6274#body_text
is schema:about of	named entity 'time' named entity 'hypotension' named entity 'comprehensive' named entity 'reagents' named entity 'Myocarditis' named entity 'core' named entity 'PRESENTING' named entity 'SOCIETY' named entity 'fulminant' named entity 'describe' named entity 'doses' named entity 'provide' named entity 'pulmonary congestion' named entity 'myocarditis' named entity 'hemodynamics' named entity 'prognosis' named entity 'drug therapy' named entity 'circulatory support' named entity 'fulminant' named entity 'lung' named entity 'myocarditis' named entity 'myocarditis' named entity 'X-ray' named entity 'fulminant' named entity 'acute myocarditis' named entity 'Cochrane' named entity 'arrhythmia' named entity 'biomarkers' named entity 'myocarditis' named entity 'bacterial infection' named entity 'pediatric' named entity 'fulminant' named entity 'ganciclovir' named entity 'Cytokines' named entity 'Sinus tachycardia' named entity 'acute phase' named entity 'arteriography' named entity 'fatigue' named entity 'fulminant' named entity 'electrolytes' named entity 'older age' named entity 'excretion' named entity 'DNA viruses' named entity 'arteriography' named entity 'prognosis' named entity 'fulminant' named entity 'pathogens' named entity 'artificial heart' named entity 'myocarditis' named entity 'IABP' named entity 'serum' named entity 'time life' named entity 'fulminant' named entity 'genome sequencing' named entity 'ulcers' named entity 'Glucocorticoids' named entity 'heart rate' named entity 'ventricular fibrillation' named entity 'life-threatening' named entity 'kidney failure'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software